Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CSTF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RASGRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TANC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPO7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM160B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MKNK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
URB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3R4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR7E24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEPD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRFN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HS3ST3A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on